<i>In vivo</i> studies have shown that knockdown of SOX4 or administration of erlotinib significantly inhibited tumor growth and reduced the rate of lymph node metastasis.<h4>Conclusion</h4>SOX4 promotes the growth and lymph node metastasis of LSCC by regulating PTBP2. Here, SOX4 is linked to neoplasm.